tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Dermatomycoses D003881 17 associated lipids
Dermatomyositis D003882 2 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diarrhea D003967 32 associated lipids
Digestive System Diseases D004066 3 associated lipids
Down Syndrome D004314 18 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Dysgammaglobulinemia D004406 3 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
Dysplastic Nevus Syndrome D004416 1 associated lipids
Dyspnea D004417 10 associated lipids
Earache D004433 2 associated lipids
Echinostomiasis D004451 1 associated lipids
Ecthyma, Contagious D004474 1 associated lipids
Eczema D004485 4 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Endomyocardial Fibrosis D004719 4 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Epidermolysis Bullosa D004820 3 associated lipids
Epididymitis D004823 1 associated lipids
Epilepsy, Temporal Lobe D004833 4 associated lipids
Erythema D004890 22 associated lipids
Erythema Nodosum D004893 5 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Erythroplasia D004919 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Exanthema D005076 11 associated lipids
Eye Diseases D005128 12 associated lipids
Facial Dermatoses D005148 7 associated lipids
Facial Neoplasms D005153 3 associated lipids
Fatigue D005221 10 associated lipids
Fatty Liver D005234 48 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Fistula D005402 8 associated lipids
Folliculitis D005499 7 associated lipids
Food Hypersensitivity D005512 7 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foot Dermatoses D005533 3 associated lipids
Fox-Fordyce Disease D005588 2 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Gastroenteritis D005759 4 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Zhang Y et al. Phosphatidylinositol 4-phosphate 5-kinase Its3 and calcineurin Ppb1 coordinately regulate cytokinesis in fission yeast. 2000 J. Biol. Chem. pmid:10950958
Kyles AE et al. Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats. 2000 Am. J. Vet. Res. pmid:10951980
Hashimoto M et al. Short-course immunosuppression using FK506 for rat tracheal allografts. 2000 J Cardiovasc Surg (Torino) pmid:10952347
Morton SJ and Powell RJ Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma. 2000 Rheumatology (Oxford) pmid:10952740
Boxenbaum H Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general. 1999 May-Aug J Pharm Pharm Sci pmid:10952769
Oliverio PJ et al. Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. 2000 AJNR Am J Neuroradiol pmid:10954277
Klauss V et al. Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy. 2000 Am. J. Cardiol. pmid:10955391
Matsuhashi N et al. Tacrolimus in corticosteroid-resistant ulcerative colitis. 2000 J. Gastroenterol. pmid:10955604
Hisamatsu T and Watanabe M Tacrolimus (FK506), a novel immunosuppressive drug for inflammatory bowel disease? 2000 J. Gastroenterol. pmid:10955609
Stahl B et al. [Tacrolimus treatment during pregnancy in organ-transplanted women]. 1999 Harefuah pmid:10959392
Uchiyama H et al. Increased urinary nitrate excretion associated with hepatic allograft rejection in experimental rat models and clinical cases. 2000 Transpl. Int. pmid:10959478
Delaney MP et al. Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170. 2000 Transpl. Int. pmid:10959480
Blomberg B and Järnerot G Clinical evaluation and management of acute severe colitis. 2000 Inflamm. Bowel Dis. pmid:10961594
Mogi M et al. Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506. 2000 Neurosci. Lett. pmid:10961655
Taylor DO Immunosuppressive therapies after heart transplantation: best, better, and beyond. 2000 Curr. Opin. Cardiol. pmid:10963148
Halloran PF Sirolimus and cyclosporin for renal transplantation. 2000 Lancet pmid:10963190
Sakamoto Y et al. Correlation between neurotoxic events and intracerebral concentration of tacrolimus in rats. 2000 Biol. Pharm. Bull. pmid:10963314
Teperman L Case studies in orthotopic liver transplantation for hepatitis B: a panel discussion. 2000 Clin Transplant pmid:10965964
Mathieson PW Cyclosporin: nephro-protective as well as nephrotoxic? 2000 Clin. Exp. Immunol. pmid:10970156
Hartmann A et al. Intracerebral abscess caused by Nocardia otitidiscaviarum in a renal transplant patient--cured by evacuation plus antibiotic therapy. 2000 Nephron pmid:10971157
Burley JR and Sihra TS A modulatory role for protein phosphatase 2B (calcineurin) in the regulation of Ca2+ entry. 2000 Eur. J. Neurosci. pmid:10971631
Jain A et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. 2000 Transplantation pmid:10972220
Khanna AK Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. 2000 Transplantation pmid:10972232
Königsrainer A et al. Nonocclusive segmental mesenteric ischemia after combined pancreas kidney transplantation: mycophenolate mofetil as an etiological factor? 2000 Transplantation pmid:10972233
Sasakawa Y et al. FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells. 2000 Eur. J. Pharmacol. pmid:10973631
Voggenreiter G et al. Immunosuppression with FK506 increases bone induction in demineralized isogeneic and xenogeneic bone matrix in the rat. 2000 J. Bone Miner. Res. pmid:10977002
Ponticelli C Calcineurin-inhibitors in renal transplantation. Too precious to be abandoned. 2000 Nephrol. Dial. Transplant. pmid:10978383
Nash RA et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. 2000 Blood pmid:10979948
Zhang W and Victor RG Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. 2000 Am. J. Hypertens. pmid:10981550
Allen C et al. PCL-b-PEO micelles as a delivery vehicle for FK506: assessment of a functional recovery of crushed peripheral nerve. 2000 Jul-Sep Drug Deliv pmid:10989914
Lohmann T et al. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus. 2000 Exp. Clin. Endocrinol. Diabetes pmid:10989953
Kane GC and Lipsky JJ Drug-grapefruit juice interactions. 2000 Mayo Clin. Proc. pmid:10994829
Lote CJ et al. The hypomagnesaemic action of FK506: urinary excretion of magnesium and calcium and the role of parathyroid hormone. 2000 Clin. Sci. pmid:10995593
Furtado A et al. Local immunosuppression in clinical small bowel transplantation (report of two cases). 2000 Transplant. Proc. pmid:10995910
Alessiani M et al. Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus. 2000 Transplant. Proc. pmid:10995915
Madariaga JR et al. The long-term efficacy of multivisceral transplantation. 2000 Transplant. Proc. pmid:10995918
Fishbein T et al. Isolated intestinal transplantation in adults with nonreconstructible GI tracts. 2000 Transplant. Proc. pmid:10995925
Alessiani M et al. Correlations between functional changes and different grades of acute rejection in swine small bowel allografts. 2000 Transplant. Proc. pmid:10995933
Kato Y et al. Epidermal growth factor enhances the intestinal adaptation of small bowel allografts in the postoperative period. 2000 Transplant. Proc. pmid:10995935
Kimura O et al. Influence of bombesin on the intestinal mucosal immunologic response under immunosuppression. 2000 Transplant. Proc. pmid:10995942
Tatekawa Y et al. Intragraft expression of p38 in rat small bowel transplantation. 2000 Transplant. Proc. pmid:10995948
Nakao A et al. Cytokine mRNA expression on rat small bowel allograft treated with tacrolimus and simultaneous bone marrow transplantation via the portal vein. 2000 Transplant. Proc. pmid:10995965
Chakrabarti P et al. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. 2000 Transplantation pmid:11003353
Inoue T et al. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. 2000 Transplantation pmid:11003356
Marchetti P and Navalesi R The metabolic effects of cyclosporin and tacrolimus. 2000 Jul-Aug J. Endocrinol. Invest. pmid:11005276
Tsaroucha AK et al. Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy. 2000 Transpl. Immunol. pmid:11005321
Dambrin C et al. Pharmacodynamics of immunosuppressive drugs. 2000 Curr. Opin. Immunol. pmid:11007359
Pham PT et al. Cyclosporine and tacrolimus-associated thrombotic microangiopathy. 2000 Am. J. Kidney Dis. pmid:11007689
Revelo MP et al. A 14-year-old boy with kidney allograft failure in the first month after transplantation. 2000 Am. J. Kidney Dis. pmid:11007695
Ideura T et al. Tacrolimus/itraconazole interactions: a case report of ABO-incompatible living-related renal transplantation. 2000 Nephrol. Dial. Transplant. pmid:11007866